5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.
about
SB 206553, a putative 5-HT2C inverse agonist, attenuates methamphetamine-seeking in ratsSerotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorderCognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A ReceptorsThe activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activityRegion-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptorsSerotonergic modulation of conditioned fear.Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice.5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in micePharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway functionReverse microdialysis of a 5-HT2A receptor antagonist alters extracellular glutamate levels in the striatum of the MPTP mouse model of Parkinson's disease.Impact of metabotropic glutamate 2/3 receptor stimulation on activated dopamine release and locomotionIn vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine.N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').Deficits in LTP induction by 5-HT2A receptor antagonist in a mouse model for fragile X syndromeThe serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens.The effect of acute tryptophan depletion on the neural correlates of emotional processing in healthy volunteers.Differential regulation of the mesoaccumbens dopamine circuit by serotonin2C receptors in the ventral tegmental area and the nucleus accumbens: an in vivo microdialysis study with cocaine.Novel mechanism of antidepressant action: norepinephrine and dopamine disinhibition (NDDI) plus melatonergic agonism.Dopamine, but not serotonin, regulates reversal learning in the marmoset caudate nucleusFine-tuning serotonin2c receptor function in the brain: molecular and functional implicationsIncreased functional connectivity in the resting-state basal ganglia network after acute heroin substitution.Dopamine dysfunction in borderline personality disorder: a hypothesis.Genotype-Dependent Difference in 5-HT2C Receptor-Induced Hypolocomotion: Comparison with 5-HT2A Receptor Functional Activity.The atypical antidepressant mirtazapine attenuates expression of morphine-induced place preference and motor sensitization.5-HT(2A) receptor blockade and 5-HT(2C) receptor activation interact to reduce cocaine hyperlocomotion and Fos protein expression in the caudate-putamenOverview of the pharmacogenomics of cigarette smoking.Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET.MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen PharmacologySelective serotonin 2A receptor antagonism attenuates the effects of amphetamine on arousal and dopamine overflow in non-human primates.Striatal serotonin 2C receptors decrease nigrostriatal dopamine release by increasing GABA-A receptor tone in the substantia nigra.Mechanism of action of trazodone: a multifunctional drug.Opponency revisited: competition and cooperation between dopamine and serotonin.Presynaptic control of serotonin on striatal dopamine function.Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology.Serotonin2C receptors and drug addiction: focus on cocaine.The role of different serotonin receptor subtypes in seizure susceptibility.Animal models for predicting the efficacy and side effects of antipsychotic drugs.Utility of preclinical drug versus food choice procedures to evaluate candidate medications for methamphetamine use disorder.
P2860
Q21262960-F7B4FB39-7E3D-46E0-9E12-5A1482AB0F07Q27015917-4917A747-697F-4FD7-A1A9-2272026860E4Q27347603-C6164E46-96B5-4F0C-957F-F63EA90C81AAQ28281024-31CE330F-2115-4B13-A645-1B81E24FB59FQ28570213-FA052341-BB45-4707-BD1A-0514B7BDD8C6Q30446862-391BF8B5-ECD3-4EBE-B6E3-CD0D253500FCQ30468504-1E4C204A-C207-4BE7-9BD7-4FECCBB63D11Q30484420-D6C231A2-C8F0-45AB-95D1-6B04D291B833Q30493133-3C20B6D1-3A7B-4E4F-8CDA-583D305EC25FQ30499670-CC8E47A9-2443-4F0D-A881-6DB4D51A20BFQ33763197-DA9BB032-FF5B-43DA-B17E-5EC237193DFEQ34197072-932630EC-9127-4DF6-AE06-2EB4150220DBQ34270096-2ABB2734-6929-42C6-8110-DAF72D4E0469Q34337802-3F9A80A3-1012-41E0-82AC-08811E4C9B52Q34360861-97730BD4-B9EA-425E-9B15-85E8A0AAAC84Q34465437-8FAA1C77-86D8-4C04-9EC9-8862BAD76894Q34546304-2C3F4192-36F8-4DF9-B572-438890729C29Q34583146-D6BB9D7B-F416-4881-AE24-F48D9A3E50A7Q34618432-B4D80FC3-37F8-423F-A59B-BBFA0C035533Q34660100-6572948C-F9F4-4F87-9866-74B1B9B87A9FQ34877029-3D84BDF2-040D-48C6-BE7E-64207AA1712CQ35072763-C137CE81-BC74-439A-ABA0-2C6AC17697CCQ35161423-A8C3C80D-D623-4396-958A-56D9B7E901AFQ35708862-C66E7A5D-8F28-401C-975E-FB8FEB8FF878Q36038551-241224B3-3CD1-4C11-9C16-D347D7B426AFQ36229381-12F8922B-A937-4D24-B2D6-778C73251AAEQ36334398-82DF13CB-958C-4B04-965A-B06CD80AE0B8Q36708951-9DD3C906-B3D8-453D-B1A6-03CD83FC9F6EQ36966673-DD630023-C93A-4BEA-9850-C16911FFD1A0Q37149027-E423E4AA-FFF6-4109-B8FB-8AC0734B1F91Q37255555-B15A96BD-C1B5-470C-888D-FE49B71ECBADQ37671124-B684283A-A445-4EDB-B862-ACE3B32D4CC6Q37679880-EDA197AC-678C-4B1D-BFD9-E6174A837D4DQ37794770-337C57E3-13D0-4F91-90A7-C1E40C2FA9E8Q37800812-D2401FAF-32FC-4D1A-ADE9-3BAA32516573Q38101499-DB400F13-B6AC-4681-9FD5-2677CC276C7AQ38113111-019FF1A8-77FA-41BE-B489-06E3A80128F5Q38162732-A189A0F9-BD8D-4EED-83AD-7A0BDC5135BBQ38165756-1E2F1F2A-9C64-4628-ADAC-690F490E9BEDQ39034288-3C16B4AD-8FAA-474E-990F-50DEC9063216
P2860
5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
5-HT2A and 5-HT2C/2B receptor ...... ucleus accumbens and striatum.
@ast
5-HT2A and 5-HT2C/2B receptor ...... ucleus accumbens and striatum.
@en
5-HT2A and 5-HT2C/2B receptor ...... ucleus accumbens and striatum.
@nl
type
label
5-HT2A and 5-HT2C/2B receptor ...... ucleus accumbens and striatum.
@ast
5-HT2A and 5-HT2C/2B receptor ...... ucleus accumbens and striatum.
@en
5-HT2A and 5-HT2C/2B receptor ...... ucleus accumbens and striatum.
@nl
prefLabel
5-HT2A and 5-HT2C/2B receptor ...... ucleus accumbens and striatum.
@ast
5-HT2A and 5-HT2C/2B receptor ...... ucleus accumbens and striatum.
@en
5-HT2A and 5-HT2C/2B receptor ...... ucleus accumbens and striatum.
@nl
P2093
P921
P1476
5-HT2A and 5-HT2C/2B receptor ...... nucleus accumbens and striatum
@en
P2093
Claudia Fracasso
Ennio Esposito
Grégory Porras
Guillaume Lucas
Silvio Caccia
Umberto Spampinato
Vincenzo Di Matteo
P304
P356
10.1016/S0893-133X(01)00333-5
P407
P577
2002-03-01T00:00:00Z
P6179
1038171925